Dynamics of changes in the concentrations of anandamide and 2-arachidonoylglycerol and their impact on the carbohydrate-lipid metabolism in patients after kidney transplantation in the follow-up study

1 Sancho R, Calzado MA, Di Marzo V, Appendino G, Muñoz E. Anandamide inhibits nuclear factor-κB activation through a cannabinoid receptor-independent pathway. Mol Pharmacol 2003;63(2):429-38. Search in Google Scholar

2 Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci USA 2001;98(16):9371-6. Search in Google Scholar

3 Gaoni Y, Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc 1964;86 (8):1646-7. Search in Google Scholar

4 Sugiura T, Kishimoto S, Oka S, Gokoh M. Biochemistry, pharmacology and physiology of 2-arachidonyloglycerol, an endogenous cannabinoid receptor ligand. Prog Lipid Res 2006;45(5):405-46. Search in Google Scholar

5 Quercioli A, Pataky Z, Vincenti G, Makoundou V, Di Marzo V, Montecucco F, et al. Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity. Eur Heart J 2011;32(11):1369-78. Search in Google Scholar

6 Di Marzo V, Côté M, Matias I, Lemieux I, Arsenault BJ, Cartier A, et al. Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors. Diabetologia 2009;52(2):213-7. Search in Google Scholar

7 Pacher P, Bátkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 2006;58(3):389-462. Search in Google Scholar

8 Nakajima Y, Furuichi Y, Biswas KK, Hashiguchi T, Kawahara K, Yamaji K, et al. Endocannabinoid, anandamide in gingival tissue regulates the periodotal inflammation through NF-κB pathway inhibiotion. FEBS Lett 2006;580(2):613-9. Search in Google Scholar

9 Jasińska A, Pietruczuk M. Adipocytokiny – białka o wielokierunkowym działaniu. J Lab Diagnost 2010;46(3)331-8. Search in Google Scholar

10 Tam J. The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases. J Basic Clin Physiol Pharmacol 2016;27(3):267-76. Search in Google Scholar

11 Sena CM, Pereira AM, Seiça R. Endothelial dysfunction – a major mediator of diabetic vascular disease. Biochim Biophys Acta 2013;1832(12):2216-31. Search in Google Scholar

12 Li J, Wang DH. Differential mechanisms mediating depressor and diuretic effects of anandamide. J Hypertens 2006;24(1):2271-6. Search in Google Scholar

13 Hsu YC, Lei CC, Shih YH, Ho C, Lin CL. Induction of proteinuria by cannabinoid receptors 1 signaling activation in CB1 transgenic mice. Am J Med Sci 2015;349(2):162-8. Search in Google Scholar

14 Barutta F, Piscitelli F, Pinach S, Bruno G, Gambino R, Rastaldi MP, et al. Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy. Diabetes 2011;60(9):2386-96. Search in Google Scholar

15 Zhang F, Hong S, Stone V, Smith PJW. Expression of cannabinoid CB1 receptors in models of diabetic neuropathy. J Pharmacol Exp Ther 2007;323(2):508-15. Search in Google Scholar

16 Engeli S, Böhnke J, Feldpausch M, Gorzelniak K, Janke J, Bátkai S, et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetes 2005;54(10):2838-43. Search in Google Scholar

17 Ruby MA, Nomura DK, Hudak CSS, Mangravite LM, Chiu S, Casida JE, et al. Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins. Proc Natl Acad Sci USA 2008;105(38):14561-6. Search in Google Scholar

18 Leśniowski B, Kumor A, Jasińska A, Pietruczuk M, Małecka-Panas E. Rezystyna – nowy marker laboratoryjny przydatny w rozpoznawaniu ostrego zapalenia trzustki. Pol Merk Lek 2007;131:385-7. Search in Google Scholar

19 Blüher M, Engeli S, Klöting N, Berndt J, Fasshauer M, Bátkai S, et al. Dys-regulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 2006;55(11):3053-60. Search in Google Scholar

20 Matias I, Gonthier MP, Orlando P, Mardiatis V, De Petrocellis L, Cervino C, et al. Regulation, function, and dysregulation of endocannabinoids in models of adipose and β-pancreatic cells and in obesity and hyperglycemia. J Clin Endocrinol Metab 2006;91(8):3171-80. Search in Google Scholar